Open AccessComparison of Efficacy and Safety of Lupin’s Pegfilgrastim with Neulastim® as an Adjunct to Chemotherapy in Patients with Non Myeloid Malignancies: A Randomised Phase III Clinical Study
Author(s) -
Minish Jain,
Sharad Desai,
Rajnish Nagarkar,
Rakesh Neve,
Unmesh Takalkar,
Dhananjay Bakhle,
Chirag Shah
Publication year - 2022
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2022/57833.16768
Subject(s) - pegfilgrastim , medicine , neutropenia , adverse effect , clinical endpoint , discontinuation , chemotherapy , febrile neutropenia , regimen , clinical trial , oncology